tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer for Bipolar-I Disorder
Company AnnouncementsBristol-Myers Squibb’s KarXT Study: A Potential Game-Changer for Bipolar-I Disorder
13h ago
BMY
Bristol-Myers Squibb’s Promising Study on Deucravacitinib for Sjögren’s Syndrome
PremiumCompany Announcements
Bristol-Myers Squibb’s Promising Study on Deucravacitinib for Sjögren’s Syndrome
13h ago
BMY
Bristol-Myers Squibb’s MYK-224 Study Termination: What Investors Need to Know
PremiumCompany Announcements
Bristol-Myers Squibb’s MYK-224 Study Termination: What Investors Need to Know
13h ago
BMY
Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
PremiumThe Fly
Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
4d ago
AZN
BMY
Bristol-Myers Squibb’s New Trial: A Potential Game-Changer for Metastatic Urothelial Cancer
PremiumCompany Announcements
Bristol-Myers Squibb’s New Trial: A Potential Game-Changer for Metastatic Urothelial Cancer
5d ago
BMY
Bristol-Myers Squibb’s Promising SLE Study: A Potential Game-Changer?
PremiumCompany AnnouncementsBristol-Myers Squibb’s Promising SLE Study: A Potential Game-Changer?
5d ago
BMY
Bristol-Myers Squibb’s Ozanimod Lactation Study: Key Insights for Investors
Premium
Company Announcements
Bristol-Myers Squibb’s Ozanimod Lactation Study: Key Insights for Investors
5d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Study on BMS-986278: A Potential Game-Changer for Pulmonary Fibrosis
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on BMS-986278: A Potential Game-Changer for Pulmonary Fibrosis
5d ago
BMY
Trump, pharma industry discuss increasing medicine spending abroad, Reuters says
PremiumThe Fly
Trump, pharma industry discuss increasing medicine spending abroad, Reuters says
5d ago
AZN
BMY
Bristol-Myers Squibb’s New Trial: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s New Trial: A Potential Game-Changer in Cancer Treatment
7d ago
BMY
Trump Weekly: President says raising tariffs on India ‘substantially’
PremiumThe Fly
Trump Weekly: President says raising tariffs on India ‘substantially’
8d ago
MU
AEO
Trump says separate tariff announcements coming for semi chips, pharmaceuticals
PremiumThe Fly
Trump says separate tariff announcements coming for semi chips, pharmaceuticals
8d ago
MU
AMD
BioNTech price target lowered to $150 from $170 at Wells Fargo
PremiumThe FlyBioNTech price target lowered to $150 from $170 at Wells Fargo
8d ago
BMY
BNTX
Bristol Myers downgraded to Neutral from Outperform at Daiwa
Premium
The Fly
Bristol Myers downgraded to Neutral from Outperform at Daiwa
8d ago
BMY
Bristol Myers says FDA accepts sBLA for Breyanzi
Premium
The Fly
Bristol Myers says FDA accepts sBLA for Breyanzi
8d ago
BMY
Bristol-Myers Squibb’s New Study on Schizophrenia Treatment Satisfaction
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study on Schizophrenia Treatment Satisfaction
9d ago
BMY
Bristol-Myers Squibb’s New Phase 3 Trial: A Potential Game-Changer in Lung Cancer Treatment?
PremiumCompany Announcements
Bristol-Myers Squibb’s New Phase 3 Trial: A Potential Game-Changer in Lung Cancer Treatment?
9d ago
BMY
Optimistic Buy Rating for Bristol-Myers Squibb Driven by Promising Drug Pipeline and Strategic Reviews
PremiumRatings
Optimistic Buy Rating for Bristol-Myers Squibb Driven by Promising Drug Pipeline and Strategic Reviews
9d ago
BMY
Bristol Myers price target lowered to $58 from $62 at Bernstein
PremiumThe Fly
Bristol Myers price target lowered to $58 from $62 at Bernstein
9d ago
BMY
Balanced Outlook on Bristol-Myers Squibb: Strong Earnings Amid Strategic Uncertainties
PremiumRatingsBalanced Outlook on Bristol-Myers Squibb: Strong Earnings Amid Strategic Uncertainties
10d ago
BMY
Bristol-Myers Squibb’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Bristol-Myers Squibb’s Earnings Call Highlights Growth and Challenges
11d ago
BMY
Bristol-Myers Squibb’s Phase 3 Study on KarXT: A Potential Game-Changer for Bipolar-I Disorder
Premium
Company Announcements
Bristol-Myers Squibb’s Phase 3 Study on KarXT: A Potential Game-Changer for Bipolar-I Disorder
12d ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >